New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Patients with challenging cancers to benefit from genomic sequencing

Patients with challenging cancers to benefit from genomic sequencing

byUniversity of MelbourneCredit: AI-generated imageMore than 1,000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosi
World medicine December 13,2023
Patients with challenging cancers to benefit from genomic sequencing

Patients with challenging cancers to benefit from genomic sequencing

byUniversity of MelbourneCredit: AI-generated imageMore than 1,000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosi
World medicine December 13,2023
High BMI may cut overall survival in HER2+, metastatic breast cancer

High BMI may cut overall survival in HER2+, metastatic breast cancer

(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (
World medicine December 13,2023
High BMI may cut overall survival in HER2+, metastatic breast cancer

High BMI may cut overall survival in HER2+, metastatic breast cancer

(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (
World medicine December 13,2023
Assessing the effects of the COVID-19 pandemic on cancer prevention

Assessing the effects of the COVID-19 pandemic on cancer prevention

byQueen Mary, University of LondonCredit: CC0 Public DomainA review of the international effects of the COVID-19 pandemic on cancer prevention, led by researchers at Queen Mary University of Lon
World medicine December 13,2023
Assessing the effects of the COVID-19 pandemic on cancer prevention

Assessing the effects of the COVID-19 pandemic on cancer prevention

byQueen Mary, University of LondonCredit: CC0 Public DomainA review of the international effects of the COVID-19 pandemic on cancer prevention, led by researchers at Queen Mary University of Lon
World medicine December 13,2023
Subcutaneous securement system best for reaching end of PICC need

Subcutaneous securement system best for reaching end of PICC need

by Elana GotkineA subcutaneous anchor securement system (SASS) is superior for assisting oncology patients to reach the end of need with a single peripherally inserted central catheter (PICC), accordi
World medicine December 13,2023
Subcutaneous securement system best for reaching end of PICC need

Subcutaneous securement system best for reaching end of PICC need

by Elana GotkineA subcutaneous anchor securement system (SASS) is superior for assisting oncology patients to reach the end of need with a single peripherally inserted central catheter (PICC), accordi
World medicine December 13,2023
Electrical signals between skin cells may influence melanoma initiation

Electrical signals between skin cells may influence melanoma initiation

byAmerican Association for Cancer ResearchHuman skin structure. Credit: WikipediaThe transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered e
World medicine December 13,2023
Electrical signals between skin cells may influence melanoma initiation

Electrical signals between skin cells may influence melanoma initiation

byAmerican Association for Cancer ResearchHuman skin structure. Credit: WikipediaThe transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered e
World medicine December 13,2023
Discovery could lead to new treatment for rare blood disease

Discovery could lead to new treatment for rare blood disease

by Adrianna MacPherson,University of Alberta Faculty of Medicine & DentistryU of A dermatologist Robert Gniadecki discovered that cancer cells found in skin lesions on patients with T cell l
World medicine December 13,2023
Discovery could lead to new treatment for rare blood disease

Discovery could lead to new treatment for rare blood disease

by Adrianna MacPherson,University of Alberta Faculty of Medicine & DentistryU of A dermatologist Robert Gniadecki discovered that cancer cells found in skin lesions on patients with T cell l
World medicine December 13,2023
Initiative helps increase breast cancer screening

Initiative helps increase breast cancer screening

bySwinburne University of TechnologyCredit: CC0 Public DomainA new study has found that using a community-codesign approach can massively increase mammography screening rates among Italian and A
World medicine December 13,2023
Initiative helps increase breast cancer screening

Initiative helps increase breast cancer screening

bySwinburne University of TechnologyCredit: CC0 Public DomainA new study has found that using a community-codesign approach can massively increase mammography screening rates among Italian and A
World medicine December 13,2023
Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

byKarolinska InstitutetThe researchers found NK cells in skin from patients with cutaneous lymphoma. Here immunofluorescence identifying CD56+CD3-NK cells (green cells, marked with yellow
World medicine December 13,2023
Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

byKarolinska InstitutetThe researchers found NK cells in skin from patients with cutaneous lymphoma. Here immunofluorescence identifying CD56+CD3-NK cells (green cells, marked with yellow
World medicine December 13,2023
Young cancer survivors at higher risk for hospitalization

Young cancer survivors at higher risk for hospitalization

(HealthDay)—Adolescent and young adult (AYA) cancer survivors (aged 15 to 39 years) have an increased risk for inpatient hospitalization, according to a study published online Jan. 20 inCancer E
World medicine December 13,2023
Young cancer survivors at higher risk for hospitalization

Young cancer survivors at higher risk for hospitalization

(HealthDay)—Adolescent and young adult (AYA) cancer survivors (aged 15 to 39 years) have an increased risk for inpatient hospitalization, according to a study published online Jan. 20 inCancer E
World medicine December 13,2023
New CAR-T target yields promising results for multiple myeloma

New CAR-T target yields promising results for multiple myeloma

by Huntsman Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Too many patients with cancers like multiple myelom
World medicine December 13,2023
New CAR-T target yields promising results for multiple myeloma

New CAR-T target yields promising results for multiple myeloma

by Huntsman Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Too many patients with cancers like multiple myelom
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com